Using holistic risk-based oversight, we can focus on a trial’s most critical factors
Let’s talk about the future of clinical trials. There’s no crystal ball, but we have plenty of data — and it shows the growing need for risk-based quality management (RBQM) in clinical research.
Recently, RBQM experts offered ideas of what’s ahead. RBQMLive, hosted by CluePoints, featured 18 industry leaders and welcomed more than 700 attendees from 27 countries. This blog highlights our discussion on the current clinical trials landscape, the factors driving change, and why the industry is embracing the RBQM model.